Hypertension in pediatric patients with chronic kidney disease: management challenges

Area of Science:

• Pediatric Nephrology
• Cardiovascular Health in Children

Background:

• Hypertension is a primary cause of chronic kidney disease (CKD) in adults, but in children, it's often a consequence.
• Unrecognized hypertension is a significant concern in pediatric CKD, potentially leading to faster kidney function decline.
• Pediatric hypertension, like in adults, is linked to accelerated CKD progression and end-stage renal disease.

Purpose of the Study:

• To highlight the importance of blood pressure management in pediatric CKD.
• To discuss current treatment guidelines and therapeutic challenges.
• To explore strategies for optimizing antihypertensive therapy in children with CKD.

Main Methods:

• Review of current evidence and clinical guidelines for pediatric CKD management.
• Analysis of therapeutic approaches for hypertension in children with CKD.
• Discussion of the role of renin-angiotensin-aldosterone system inhibitors and diuretics.

Main Results:

• New guidelines recommend targeting blood pressure below the 50th percentile for age, sex, and height in children with proteinuria and CKD.
• Monotherapy is often insufficient, necessitating combination therapy.
• Renin-angiotensin-aldosterone system blockade is a primary treatment, but hyperkalemia is a common limitation.

Conclusions:

• Aggressive blood pressure control is crucial for managing pediatric CKD.
• Combination therapy, including diuretics, may be necessary to achieve target blood pressure and manage side effects like hyperkalemia.
• Early and effective management of hypertension is vital to slow CKD progression in children.